1. Home
  2. MXF vs NERV Comparison

MXF vs NERV Comparison

Compare MXF & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mexico Fund Inc. (The)

MXF

Mexico Fund Inc. (The)

HOLD

Current Price

$22.00

Market Cap

311.9M

Sector

Finance

ML Signal

HOLD

Logo Minerva Neurosciences Inc

NERV

Minerva Neurosciences Inc

HOLD

Current Price

$4.85

Market Cap

301.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MXF
NERV
Founded
N/A
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
311.9M
301.6M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
MXF
NERV
Price
$22.00
$4.85
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$10.50
AVG Volume (30 Days)
53.0K
127.5K
Earning Date
01-01-0001
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$41,175,600.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.43
$1.57
52 Week High
$23.00
$12.46

Technical Indicators

Market Signals
Indicator
MXF
NERV
Relative Strength Index (RSI) 51.74 37.30
Support Level $20.96 $3.69
Resistance Level $22.34 $5.61
Average True Range (ATR) 0.42 0.45
MACD 0.00 -0.02
Stochastic Oscillator 59.25 36.88

Price Performance

Historical Comparison
MXF
NERV

About MXF Mexico Fund Inc. (The)

Mexico Fund Inc is a United States-based non-diversified, closed-end management investment company. Its investment objective is to seek long-term capital appreciation. The fund seeks to achieve its objective through investment in securities, primary in equity, listed on the Mexican Stock Exchange. The company's portfolio of investments consists of investments in different sectors such as auto parts, airports, building materials, chemical products, consumer products, energy, food, and other sectors. The fund provides a vehicle to investors who wish to invest in Mexican companies through a managed non-diversified portfolio as part of their overall investment program.

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.

Share on Social Networks: